Trial Profile
A retrospective study of denosumab in postmenopausal osteoporosis patients with and without prior bisphosphonates treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- 13 Jan 2017 New trial record